Brca1 | Rat | (+)-schisandrin B | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of BRCA1 mRNA] | CTD | PMID:31150632 |
Brca1 | Rat | (-)-alpha-phellandrene | decreases expression | ISO | Brca1 (Mus musculus) | 6480464 | alpha phellandrene results in decreased expression of BRCA1 protein | CTD | PMID:24861204 |
Brca1 | Rat | (-)-epigallocatechin 3-gallate | multiple interactions | ISO | BRCA1 (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of BRCA1 mRNA | CTD | PMID:22079256 |
Brca1 | Rat | (-)-epigallocatechin 3-gallate | increases expression | ISO | BRCA1 (Homo sapiens) | 6480464 | epigallocatechin gallate results in increased expression of BRCA1 mRNA | CTD | PMID:25839702 |
Brca1 | Rat | (S)-naringenin | multiple interactions | ISO | BRCA1 (Homo sapiens) | 6480464 | [naringenin co-treated with bisphenol A] results in increased expression of BRCA1 mRNA and [naringenin metabolite co-treated with bisphenol A] results in increased expression of BRCA1 mRNA | CTD | PMID:36235125 |
Brca1 | Rat | (S)-nicotine | decreases expression | ISO | BRCA1 (Homo sapiens) | 6480464 | Nicotine results in decreased expression of BRCA1 mRNA | CTD | PMID:18247414 |
Brca1 | Rat | (S)-nicotine | multiple interactions | ISO | BRCA1 (Homo sapiens) | 6480464 | Nicotine inhibits the reaction [aflatoxin G1 results in increased expression of BRCA1 protein modified form] | CTD | PMID:23907605 |
Brca1 | Rat | 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane | increases expression | ISO | BRCA1 (Homo sapiens) | 6480464 | o and p'-DDT results in increased expression of BRCA1 mRNA | CTD | PMID:20206645 |
Brca1 | Rat | 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane | multiple interactions | ISO | BRCA1 (Homo sapiens) | 6480464 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [o more ... | CTD | PMID:20206645 |
Brca1 | Rat | 1,1-dichloroethene | increases expression | ISO | Brca1 (Mus musculus) | 6480464 | vinylidene chloride results in increased expression of BRCA1 mRNA | CTD | PMID:26682919 |
Brca1 | Rat | 1-naphthyl isothiocyanate | increases expression | EXP | | 6480464 | 1-Naphthylisothiocyanate results in increased expression of BRCA1 mRNA | CTD | PMID:30723492 |
Brca1 | Rat | 1-nitropyrene | decreases expression | ISO | BRCA1 (Homo sapiens) | 6480464 | 1-nitropyrene results in decreased expression of BRCA1 mRNA | CTD | PMID:21540303 |
Brca1 | Rat | 17beta-estradiol | increases expression | ISO | Brca1 (Mus musculus) | 6480464 | Estradiol results in increased expression of BRCA1 mRNA | CTD | PMID:25210133 |
Brca1 | Rat | 17beta-estradiol | decreases expression | ISO | Brca1 (Mus musculus) | 6480464 | Estradiol results in decreased expression of BRCA1 mRNA | CTD | PMID:39298647 |
Brca1 | Rat | 17beta-estradiol | decreases expression | ISO | BRCA1 (Homo sapiens) | 6480464 | Estradiol results in decreased expression of BRCA1 mRNA | CTD | PMID:23373633 |
Brca1 | Rat | 17beta-estradiol | increases expression | ISO | BRCA1 (Homo sapiens) | 6480464 | Estradiol results in increased expression of BRCA1 mRNA and Estradiol results in increased expression of BRCA1 protein | CTD | PMID:12473173 more ... |
Brca1 | Rat | 17beta-estradiol | affects localization | ISO | BRCA1 (Homo sapiens) | 6480464 | Estradiol affects the localization of BRCA1 protein | CTD | PMID:16061635 |
Brca1 | Rat | 17beta-estradiol | multiple interactions | ISO | BRCA1 (Homo sapiens) | 6480464 | 2 more ... | CTD | PMID:11110848 more ... |
Brca1 | Rat | 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one | increases expression | ISO | BRCA1 (Homo sapiens) | 6480464 | Metribolone results in increased expression of BRCA1 mRNA | CTD | PMID:17010196 |
Brca1 | Rat | 2,2',4,4',5,5'-hexachlorobiphenyl | multiple interactions | ISO | BRCA1 (Homo sapiens) | 6480464 | 2 more ... | CTD | PMID:12473173 |
Brca1 | Rat | 2,2',4,4'-Tetrabromodiphenyl ether | decreases expression | EXP | | 6480464 | 2 more ... | CTD | PMID:20566336 |
Brca1 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Brca1 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone] results in increased expression of BRCA1 mRNA | CTD | PMID:21167638 |
Brca1 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases methylation | ISO | BRCA1 (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin results in increased methylation of BRCA1 promoter | CTD | PMID:22197621 |
Brca1 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | BRCA1 (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of BRCA1 mRNA and Tetrachlorodibenzodioxin results in decreased expression of BRCA1 protein | CTD | PMID:20631324 and PMID:22197621 |
Brca1 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | BRCA1 (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin affects the expression of BRCA1 mRNA | CTD | PMID:22298810 and PMID:22574217 |
Brca1 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases methylation | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased methylation of BRCA1 promoter | CTD | PMID:24136580 |
Brca1 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of BRCA1 mRNA | CTD | PMID:22298810 and PMID:32109520 |
Brca1 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of BRCA1 mRNA and Tetrachlorodibenzodioxin results in decreased expression of BRCA1 protein | CTD | PMID:24136580 and PMID:33387578 |
Brca1 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | BRCA1 protein promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA] more ... | CTD | PMID:16567799 and PMID:24136580 |
Brca1 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Brca1 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of BRCA1 mRNA | CTD | PMID:19465110 |
Brca1 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | BRCA1 (Homo sapiens) | 6480464 | [[Tetrachlorodibenzodioxin binds to and results in increased activity of AHR protein] promotes the reaction [AHR protein binds to BRCA1 promoter]] inhibits the reaction [Estradiol results in increased expression of BRCA1 mRNA] more ... | CTD | PMID:12473173 more ... |
Brca1 | Rat | 2-acetamidofluorene | increases expression | EXP | | 6480464 | 2-Acetylaminofluorene results in increased expression of BRCA1 mRNA | CTD | PMID:19167416 |
Brca1 | Rat | 2-butoxyethanol | increases expression | ISO | Brca1 (Mus musculus) | 6480464 | n-butoxyethanol results in increased expression of BRCA1 mRNA | CTD | PMID:19812364 |
Brca1 | Rat | 2-methylcholine | affects expression | ISO | BRCA1 (Homo sapiens) | 6480464 | beta-methylcholine affects the expression of BRCA1 mRNA | CTD | PMID:21179406 |
Brca1 | Rat | 2-naphthylamine | decreases expression | ISO | BRCA1 (Homo sapiens) | 6480464 | 2-Naphthylamine results in decreased expression of BRCA1 mRNA | CTD | PMID:18247414 |
Brca1 | Rat | 3,3',4,4',5-pentachlorobiphenyl | increases expression | EXP | | 6480464 | 3 more ... | CTD | PMID:23196670 |
Brca1 | Rat | 3-methylcholanthrene | multiple interactions | ISO | BRCA1 (Homo sapiens) | 6480464 | Methylcholanthrene promotes the reaction [AHR protein binds to BRCA1 protein] | CTD | PMID:18259752 |
Brca1 | Rat | 3-methylcholanthrene | increases expression | ISO | Brca1 (Mus musculus) | 6480464 | Methylcholanthrene results in increased expression of BRCA1 mRNA | CTD | PMID:20713471 |
Brca1 | Rat | 4,4'-sulfonyldiphenol | decreases expression | ISO | Brca1 (Mus musculus) | 6480464 | bisphenol S results in decreased expression of BRCA1 mRNA | CTD | PMID:39298647 |
Brca1 | Rat | 4,4'-sulfonyldiphenol | multiple interactions | ISO | BRCA1 (Homo sapiens) | 6480464 | [bisphenol S co-treated with Fulvestrant] results in increased methylation of BRCA1 gene | CTD | PMID:31601247 |
Brca1 | Rat | 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one | increases expression | ISO | Brca1 (Mus musculus) | 6480464 | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of BRCA1 mRNA | CTD | PMID:21167638 |
Brca1 | Rat | 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one | multiple interactions | ISO | Brca1 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone] results in increased expression of BRCA1 mRNA | CTD | PMID:21167638 |
Brca1 | Rat | 5-aza-2'-deoxycytidine | affects localization | ISO | BRCA1 (Homo sapiens) | 6480464 | Decitabine affects the localization of BRCA1 protein modified form | CTD | PMID:17991895 |
Brca1 | Rat | 5-fluorouracil | increases expression | ISO | BRCA1 (Homo sapiens) | 6480464 | Fluorouracil results in increased expression of BRCA1 mRNA | CTD | PMID:16101138 and PMID:16557594 |
Brca1 | Rat | 5-fluorouracil | decreases expression | ISO | BRCA1 (Homo sapiens) | 6480464 | Fluorouracil results in decreased expression of BRCA1 mRNA | CTD | PMID:15607317 and PMID:17982676 |
Brca1 | Rat | 5-fluorouracil | multiple interactions | ISO | BRCA1 (Homo sapiens) | 6480464 | TP53 protein inhibits the reaction [Fluorouracil results in decreased expression of BRCA1 mRNA] | CTD | PMID:17982676 |
Brca1 | Rat | 7,12-dimethyltetraphene | affects response to substance | ISO | BRCA1 (Homo sapiens) | 6480464 | BRCA1 protein affects the susceptibility to 9 more ... | CTD | PMID:21507987 |
Brca1 | Rat | 7,12-dimethyltetraphene | increases expression | ISO | Brca1 (Mus musculus) | 6480464 | 9 more ... | CTD | PMID:25448685 |
Brca1 | Rat | 7,12-dimethyltetraphene | multiple interactions | ISO | Brca1 (Mus musculus) | 6480464 | 9 more ... | CTD | PMID:25448685 |
Brca1 | Rat | 7,12-dimethyltetraphene | increases expression | EXP | | 6480464 | 9 more ... | CTD | PMID:23969067 |
Brca1 | Rat | 7,9-dihydro-1H-purine-2,6,8(3H)-trione | decreases expression | ISO | Brca1 (Mus musculus) | 6480464 | Uric Acid results in decreased expression of BRCA1 mRNA | CTD | PMID:23619996 |
Brca1 | Rat | 7,9-dihydro-1H-purine-2,6,8(3H)-trione | multiple interactions | ISO | Brca1 (Mus musculus) | 6480464 | NLRP3 gene mutant form inhibits the reaction [Uric Acid results in decreased expression of BRCA1 mRNA] | CTD | PMID:23619996 |
Brca1 | Rat | 8-hydroxy-2'-deoxyguanosine | multiple interactions | ISO | Brca1 (Mus musculus) | 6480464 | [BRCA1 gene mutant form results in increased susceptibility to Ethanol] which results in increased abundance of 8-Hydroxy-2'-Deoxyguanosine | CTD | PMID:26629949 |
Brca1 | Rat | acetamide | increases expression | EXP | | 6480464 | acetamide results in increased expression of BRCA1 mRNA | CTD | PMID:31881176 |
Brca1 | Rat | acetylsalicylic acid | decreases expression | ISO | BRCA1 (Homo sapiens) | 6480464 | Aspirin results in decreased expression of BRCA1 mRNA | CTD | PMID:20457246 and PMID:20514442 |
Brca1 | Rat | acrolein | multiple interactions | ISO | BRCA1 (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of BRCA1 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of BRCA1 mRNA | CTD | PMID:32699268 |
Brca1 | Rat | acrylamide | decreases expression | EXP | | 6480464 | Acrylamide results in decreased expression of BRCA1 mRNA | CTD | PMID:28606764 |
Brca1 | Rat | Aflatoxin G1 | increases activity | ISO | BRCA1 (Homo sapiens) | 6480464 | aflatoxin G1 results in increased activity of BRCA1 protein | CTD | PMID:23907605 |
Brca1 | Rat | Aflatoxin G1 | increases expression | ISO | BRCA1 (Homo sapiens) | 6480464 | aflatoxin G1 results in increased expression of BRCA1 protein modified form | CTD | PMID:23907605 |
Brca1 | Rat | Aflatoxin G1 | multiple interactions | ISO | BRCA1 (Homo sapiens) | 6480464 | Methoxsalen inhibits the reaction [aflatoxin G1 results in increased expression of BRCA1 protein modified form] and Nicotine inhibits the reaction [aflatoxin G1 results in increased expression of BRCA1 protein modified form] | CTD | PMID:23907605 |
Brca1 | Rat | all-trans-retinoic acid | increases expression | ISO | BRCA1 (Homo sapiens) | 6480464 | Tretinoin results in increased expression of BRCA1 mRNA | CTD | PMID:16054129 |
Brca1 | Rat | all-trans-retinoic acid | decreases expression | ISO | BRCA1 (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of BRCA1 mRNA | CTD | PMID:15498508 and PMID:33167477 |
Brca1 | Rat | all-trans-retinoic acid | increases expression | ISO | Brca1 (Mus musculus) | 6480464 | Tretinoin results in increased expression of BRCA1 mRNA | CTD | PMID:17198874 |
Brca1 | Rat | allethrin | multiple interactions | EXP | | 6480464 | [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of BRCA1 protein | CTD | PMID:34896426 |
Brca1 | Rat | alpha-naphthoflavone | multiple interactions | ISO | BRCA1 (Homo sapiens) | 6480464 | alpha-naphthoflavone inhibits the reaction [[Tetrachlorodibenzodioxin binds to AHR protein] which results in increased activity of BRCA1 protein] and alpha-naphthoflavone inhibits the reaction [Estradiol results in increased expression of BRCA1 mRNA] | CTD | PMID:16489025 and PMID:18259752 |
Brca1 | Rat | alpha-phellandrene | decreases expression | ISO | Brca1 (Mus musculus) | 6480464 | alpha phellandrene results in decreased expression of BRCA1 protein | CTD | PMID:24861204 |
Brca1 | Rat | alpha-pinene | multiple interactions | ISO | BRCA1 (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of BRCA1 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of BRCA1 mRNA | CTD | PMID:32699268 |
Brca1 | Rat | amiodarone | increases expression | ISO | Brca1 (Mus musculus) | 6480464 | Amiodarone results in increased expression of BRCA1 mRNA | CTD | PMID:24489787 |
Brca1 | Rat | ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of BRCA1 mRNA | CTD | PMID:16483693 |
Brca1 | Rat | arecoline | decreases expression | ISO | BRCA1 (Homo sapiens) | 6480464 | Arecoline results in decreased expression of BRCA1 mRNA | CTD | PMID:17682004 |
Brca1 | Rat | arsane | affects methylation | ISO | BRCA1 (Homo sapiens) | 6480464 | Arsenic affects the methylation of BRCA1 gene | CTD | PMID:25304211 |
Brca1 | Rat | arsane | multiple interactions | ISO | BRCA1 (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of BRCA1 mRNA | CTD | PMID:39836092 |
Brca1 | Rat | arsane | increases expression | ISO | BRCA1 (Homo sapiens) | 6480464 | Arsenic results in increased expression of BRCA1 mRNA | CTD | PMID:36720308 |
Brca1 | Rat | arsenic atom | affects methylation | ISO | BRCA1 (Homo sapiens) | 6480464 | Arsenic affects the methylation of BRCA1 gene | CTD | PMID:25304211 |
Brca1 | Rat | arsenic atom | multiple interactions | ISO | BRCA1 (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of BRCA1 mRNA | CTD | PMID:39836092 |
Brca1 | Rat | arsenic atom | increases expression | ISO | BRCA1 (Homo sapiens) | 6480464 | Arsenic results in increased expression of BRCA1 mRNA | CTD | PMID:36720308 |
Brca1 | Rat | arsenite(3-) | decreases expression | ISO | BRCA1 (Homo sapiens) | 6480464 | arsenite results in decreased expression of BRCA1 mRNA | CTD | PMID:31646340 |
Brca1 | Rat | arsenous acid | increases expression | ISO | BRCA1 (Homo sapiens) | 6480464 | Arsenic Trioxide results in increased expression of BRCA1 mRNA | CTD | PMID:20458559 |
Brca1 | Rat | asbestos | affects response to substance | ISO | BRCA1 (Homo sapiens) | 6480464 | BRCA1 alternative form affects the susceptibility to Asbestos | CTD | PMID:28687356 |
Brca1 | Rat | atrazine | decreases expression | ISO | BRCA1 (Homo sapiens) | 6480464 | Atrazine results in decreased expression of BRCA1 mRNA | CTD | PMID:22378314 |
Brca1 | Rat | benzo[a]pyrene | multiple interactions | ISO | BRCA1 (Homo sapiens) | 6480464 | ARNT protein affects the reaction [BRCA1 protein affects the susceptibility to Benzo(a)pyrene] more ... | CTD | PMID:11782367 more ... |
Brca1 | Rat | benzo[a]pyrene | affects methylation | ISO | BRCA1 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of BRCA1 promoter | CTD | PMID:27901495 |
Brca1 | Rat | benzo[a]pyrene | decreases expression | ISO | BRCA1 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased expression of BRCA1 mRNA | CTD | PMID:11782367 more ... |
Brca1 | Rat | benzo[a]pyrene | increases expression | ISO | BRCA1 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased expression of BRCA1 mRNA | CTD | PMID:28461126 more ... |
Brca1 | Rat | benzo[a]pyrene | affects response to substance | ISO | Brca1 (Mus musculus) | 6480464 | BRCA1 protein affects the susceptibility to Benzo(a)pyrene | CTD | PMID:21507987 |
Brca1 | Rat | benzo[a]pyrene | increases expression | ISO | Brca1 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of BRCA1 mRNA | CTD | PMID:20713471 |
Brca1 | Rat | benzo[a]pyrene | decreases expression | ISO | Brca1 (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of BRCA1 mRNA | CTD | PMID:17942131 |
Brca1 | Rat | benzo[a]pyrene | affects response to substance | ISO | BRCA1 (Homo sapiens) | 6480464 | BRCA1 protein affects the susceptibility to Benzo(a)pyrene | CTD | PMID:21507987 |
Brca1 | Rat | benzo[a]pyrene diol epoxide I | multiple interactions | ISO | BRCA1 (Homo sapiens) | 6480464 | TP53 protein promotes the reaction [7 more ... | CTD | PMID:11782367 |
Brca1 | Rat | benzo[a]pyrene diol epoxide I | affects expression | ISO | BRCA1 (Homo sapiens) | 6480464 | 7 more ... | CTD | PMID:34454013 |
Brca1 | Rat | benzo[a]pyrene diol epoxide I | decreases expression | ISO | BRCA1 (Homo sapiens) | 6480464 | 7 more ... | CTD | PMID:11782367 and PMID:20382639 |
Brca1 | Rat | benzophenanthridine | decreases expression | ISO | BRCA1 (Homo sapiens) | 6480464 | Benzophenanthridines analog results in decreased expression of BRCA1 mRNA | CTD | PMID:23117580 |
Brca1 | Rat | beta-hexachlorocyclohexane | multiple interactions | ISO | BRCA1 (Homo sapiens) | 6480464 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [beta-hexachlorocyclohexane results in increased expression of BRCA1 mRNA] and fulvestrant inhibits the reaction [beta-hexachlorocyclohexane results in increased expression of BRCA1 mRNA] | CTD | PMID:20206645 |
Brca1 | Rat | beta-hexachlorocyclohexane | increases expression | ISO | BRCA1 (Homo sapiens) | 6480464 | beta-hexachlorocyclohexane results in increased expression of BRCA1 mRNA | CTD | PMID:20206645 |
Brca1 | Rat | bifenthrin | affects binding | ISO | BRCA1 (Homo sapiens) | 6480464 | bifenthrin binds to BRCA1 protein | CTD | PMID:32278787 |
Brca1 | Rat | biphenyl-4-amine | decreases expression | ISO | BRCA1 (Homo sapiens) | 6480464 | 4-biphenylamine results in decreased expression of BRCA1 mRNA | CTD | PMID:24857880 and PMID:32905825 |
Brca1 | Rat | biphenyl-4-amine | multiple interactions | ISO | BRCA1 (Homo sapiens) | 6480464 | TP53 protein inhibits the reaction [4-biphenylamine results in decreased expression of BRCA1 mRNA] | CTD | PMID:32905825 |
Brca1 | Rat | bis(2-chloroethyl) sulfide | decreases expression | ISO | BRCA1 (Homo sapiens) | 6480464 | Mustard Gas results in decreased expression of BRCA1 mRNA | CTD | PMID:33491125 |
Brca1 | Rat | bis(2-ethylhexyl) phthalate | increases expression | ISO | Brca1 (Mus musculus) | 6480464 | Diethylhexyl Phthalate results in increased expression of BRCA1 mRNA | CTD | PMID:36423848 |
Brca1 | Rat | bisphenol A | increases methylation | ISO | BRCA1 (Homo sapiens) | 6480464 | bisphenol A results in increased methylation of BRCA1 gene | CTD | PMID:22258036 |
Brca1 | Rat | bisphenol A | increases methylation | ISO | Brca1 (Mus musculus) | 6480464 | bisphenol A results in increased methylation of BRCA1 promoter | CTD | PMID:27312807 |
Brca1 | Rat | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of BRCA1 mRNA | CTD | PMID:27208089 and PMID:32145629 |
Brca1 | Rat | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of BRCA1 mRNA | CTD | PMID:25181051 |
Brca1 | Rat | bisphenol A | increases expression | ISO | BRCA1 (Homo sapiens) | 6480464 | bisphenol A results in increased expression of BRCA1 mRNA and bisphenol A results in increased expression of BRCA1 protein | CTD | PMID:22576693 and PMID:25933419 |
Brca1 | Rat | bisphenol A | increases response to substance | ISO | Brca1 (Mus musculus) | 6480464 | BRCA1 gene mutant form results in increased susceptibility to bisphenol A | CTD | PMID:20868731 |
Brca1 | Rat | bisphenol A | affects response to substance | ISO | BRCA1 (Homo sapiens) | 6480464 | BRCA1 protein affects the susceptibility to bisphenol A | CTD | PMID:20868731 |
Brca1 | Rat | bisphenol A | multiple interactions | ISO | BRCA1 (Homo sapiens) | 6480464 | [bisphenol A co-treated with Fulvestrant] results in increased methylation of BRCA1 gene more ... | CTD | PMID:20868731 more ... |
Brca1 | Rat | bisphenol A | decreases expression | ISO | BRCA1 (Homo sapiens) | 6480464 | bisphenol A results in decreased expression of BRCA1 mRNA | CTD | PMID:16029874 |
Brca1 | Rat | bortezomib | decreases expression | ISO | BRCA1 (Homo sapiens) | 6480464 | Bortezomib results in decreased expression of BRCA1 mRNA | CTD | PMID:21917757 |
Brca1 | Rat | bortezomib | multiple interactions | ISO | Brca1 (Mus musculus) | 6480464 | BRCA1 protein inhibits the reaction [BRCA1 gene mutant form results in increased susceptibility to Bortezomib] | CTD | PMID:25522274 |
Brca1 | Rat | bortezomib | increases response to substance | ISO | Brca1 (Mus musculus) | 6480464 | BRCA1 gene mutant form results in increased susceptibility to Bortezomib | CTD | PMID:25522274 |
Brca1 | Rat | bortezomib | multiple interactions | ISO | BRCA1 (Homo sapiens) | 6480464 | [BRCA1 mutant form results in increased susceptibility to Bortezomib] which results in decreased expression of AKR7A2 mRNA more ... | CTD | PMID:25522274 |
Brca1 | Rat | bortezomib | decreases ubiquitination | ISO | BRCA1 (Homo sapiens) | 6480464 | Bortezomib results in decreased ubiquitination of BRCA1 protein | CTD | PMID:21917757 |
Brca1 | Rat | bortezomib | increases response to substance | ISO | BRCA1 (Homo sapiens) | 6480464 | BRCA1 mutant form results in increased susceptibility to Bortezomib | CTD | PMID:25522274 |
Brca1 | Rat | bromoacetate | decreases expression | ISO | BRCA1 (Homo sapiens) | 6480464 | bromoacetate results in decreased expression of BRCA1 mRNA | CTD | PMID:19753638 |
Brca1 | Rat | cadmium atom | decreases expression | ISO | BRCA1 (Homo sapiens) | 6480464 | Cadmium results in decreased expression of BRCA1 mRNA and Cadmium results in decreased expression of BRCA1 protein | CTD | PMID:20049202 and PMID:31646340 |
Brca1 | Rat | cadmium dichloride | decreases expression | ISO | BRCA1 (Homo sapiens) | 6480464 | Cadmium Chloride results in decreased expression of BRCA1 mRNA | CTD | PMID:26525392 |
Brca1 | Rat | caffeine | affects phosphorylation | ISO | BRCA1 (Homo sapiens) | 6480464 | Caffeine affects the phosphorylation of BRCA1 protein | CTD | PMID:35688186 |
Brca1 | Rat | calcitriol | multiple interactions | ISO | BRCA1 (Homo sapiens) | 6480464 | [Testosterone co-treated with Calcitriol] results in decreased expression of BRCA1 mRNA more ... | CTD | PMID:21592394 |
Brca1 | Rat | calcitriol | decreases expression | ISO | BRCA1 (Homo sapiens) | 6480464 | Calcitriol results in decreased expression of BRCA1 mRNA | CTD | PMID:21592394 |
Brca1 | Rat | Calcium propionate | affects response to substance | ISO | BRCA1 (Homo sapiens) | 6480464 | BRCA1 exon mutant form affects the susceptibility to calcium propionate | CTD | PMID:31333813 |
Brca1 | Rat | camptothecin | decreases response to substance | ISO | BRCA1 (Homo sapiens) | 6480464 | BRCA1 mRNA results in decreased susceptibility to Camptothecin | CTD | PMID:25269479 |
Brca1 | Rat | camptothecin | decreases expression | ISO | BRCA1 (Homo sapiens) | 6480464 | Camptothecin results in decreased expression of BRCA1 mRNA | CTD | PMID:10344722 |
Brca1 | Rat | cannabidiol | decreases expression | ISO | BRCA1 (Homo sapiens) | 6480464 | Cannabidiol results in decreased expression of BRCA1 mRNA | CTD | PMID:33244087 and PMID:36519830 |
Brca1 | Rat | cannabidiol | multiple interactions | ISO | BRCA1 (Homo sapiens) | 6480464 | [Cannabidiol co-treated with moringin] results in increased expression of BRCA1 mRNA | CTD | PMID:30096889 |
Brca1 | Rat | cannabidiol | increases expression | ISO | BRCA1 (Homo sapiens) | 6480464 | Cannabidiol results in increased expression of BRCA1 mRNA | CTD | PMID:27918106 |
Brca1 | Rat | carboplatin | decreases activity | ISO | BRCA1 (Homo sapiens) | 6480464 | Carboplatin results in decreased activity of BRCA1 protein | CTD | PMID:20878461 |
Brca1 | Rat | carfilzomib | increases response to substance | ISO | BRCA1 (Homo sapiens) | 6480464 | BRCA1 mutant form results in increased susceptibility to carfilzomib | CTD | PMID:25522274 |
Brca1 | Rat | casticin | increases expression | ISO | BRCA1 (Homo sapiens) | 6480464 | casticin results in increased expression of BRCA1 protein | CTD | PMID:29098808 |
Brca1 | Rat | ceric oxide | decreases expression | EXP | | 6480464 | ceric oxide results in decreased expression of BRCA1 mRNA | CTD | PMID:29463257 |
Brca1 | Rat | CGP 52608 | multiple interactions | ISO | BRCA1 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to BRCA1 gene] | CTD | PMID:28238834 |
Brca1 | Rat | chlorpyrifos | decreases expression | ISO | Brca1 (Mus musculus) | 6480464 | Chlorpyrifos results in decreased expression of BRCA1 mRNA | CTD | PMID:37019170 |
Brca1 | Rat | choline | multiple interactions | ISO | Brca1 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of BRCA1 mRNA | CTD | PMID:20938992 |
Brca1 | Rat | cisplatin | multiple interactions | ISO | BRCA1 (Homo sapiens) | 6480464 | [Cisplatin results in decreased susceptibility to Cisplatin] which results in increased expression of BRCA1 mRNA more ... | CTD | PMID:20623183 more ... |
Brca1 | Rat | cisplatin | increases expression | ISO | BRCA1 (Homo sapiens) | 6480464 | Cisplatin results in increased expression of BRCA1 mRNA and Cisplatin results in increased expression of BRCA1 protein | CTD | PMID:20623183 and PMID:27594783 |
Brca1 | Rat | cisplatin | decreases response to substance | ISO | BRCA1 (Homo sapiens) | 6480464 | BRCA1 protein results in decreased susceptibility to Cisplatin and BRCA1 results in decreased susceptibility to Cisplatin | CTD | PMID:20603439 more ... |
Brca1 | Rat | cisplatin | increases phosphorylation | ISO | Brca1 (Mus musculus) | 6480464 | Cisplatin results in increased phosphorylation of BRCA1 protein | CTD | PMID:22006019 |
Brca1 | Rat | cisplatin | increases expression | ISO | Brca1 (Mus musculus) | 6480464 | Cisplatin results in increased expression of BRCA1 mRNA | CTD | PMID:21151649 |
Brca1 | Rat | cisplatin | decreases response to substance | ISO | Brca1 (Mus musculus) | 6480464 | BRCA1 results in decreased susceptibility to Cisplatin | CTD | PMID:21771338 |
Brca1 | Rat | cisplatin | decreases activity | ISO | BRCA1 (Homo sapiens) | 6480464 | Cisplatin results in decreased activity of BRCA1 protein | CTD | PMID:20878461 |
Brca1 | Rat | cobalt dichloride | decreases expression | ISO | BRCA1 (Homo sapiens) | 6480464 | cobaltous chloride results in decreased expression of BRCA1 mRNA | CTD | PMID:19376846 |
Brca1 | Rat | copper atom | multiple interactions | ISO | BRCA1 (Homo sapiens) | 6480464 | [Chelating Agents binds to Copper] which results in increased expression of BRCA1 mRNA | CTD | PMID:30911355 |
Brca1 | Rat | copper(0) | multiple interactions | ISO | BRCA1 (Homo sapiens) | 6480464 | [Chelating Agents binds to Copper] which results in increased expression of BRCA1 mRNA | CTD | PMID:30911355 |
Brca1 | Rat | copper(II) sulfate | affects expression | ISO | BRCA1 (Homo sapiens) | 6480464 | Copper Sulfate affects the expression of BRCA1 mRNA | CTD | PMID:19549813 |
Brca1 | Rat | coumarin | affects phosphorylation | ISO | BRCA1 (Homo sapiens) | 6480464 | coumarin affects the phosphorylation of BRCA1 protein | CTD | PMID:35688186 |
Brca1 | Rat | coumestrol | multiple interactions | ISO | BRCA1 (Homo sapiens) | 6480464 | [Coumestrol co-treated with 2 more ... | CTD | PMID:19167446 |
Brca1 | Rat | coumestrol | increases expression | ISO | BRCA1 (Homo sapiens) | 6480464 | Coumestrol results in increased expression of BRCA1 mRNA | CTD | PMID:19167446 |
Brca1 | Rat | crocidolite asbestos | affects expression | ISO | BRCA1 (Homo sapiens) | 6480464 | Asbestos and Crocidolite affects the expression of BRCA1 mRNA | CTD | PMID:17331233 |
Brca1 | Rat | curcumin | multiple interactions | ISO | BRCA1 (Homo sapiens) | 6480464 | Curcumin inhibits the reaction [Furazolidone results in increased expression of BRCA1 protein] | CTD | PMID:27996348 |
Brca1 | Rat | cycloheximide | multiple interactions | ISO | BRCA1 (Homo sapiens) | 6480464 | Cycloheximide inhibits the reaction [Nitrogen Mustard Compounds results in decreased expression of BRCA1 mRNA] | CTD | PMID:10344722 |
Brca1 | Rat | cycloheximide | multiple interactions | ISO | Brca1 (Mus musculus) | 6480464 | BAP1 inhibits the reaction [Cycloheximide results in increased degradation of BRCA1 protein] and Cycloheximide inhibits the reaction [Thapsigargin affects the localization of BRCA1 mRNA] | CTD | PMID:29576526 and PMID:37414201 |
Brca1 | Rat | cyclosporin A | decreases expression | ISO | Brca1 (Mus musculus) | 6480464 | Cyclosporine results in decreased expression of BRCA1 mRNA | CTD | PMID:17942131 and PMID:19770486 |
Brca1 | Rat | cyclosporin A | decreases expression | ISO | BRCA1 (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of BRCA1 mRNA | CTD | PMID:21632981 and PMID:25562108 |
Brca1 | Rat | cyhalothrin | multiple interactions | EXP | | 6480464 | [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of BRCA1 protein | CTD | PMID:34896426 |
Brca1 | Rat | cypermethrin | decreases expression | ISO | BRCA1 (Homo sapiens) | 6480464 | cypermethrin results in decreased expression of BRCA1 protein | CTD | PMID:36063984 |
Brca1 | Rat | cypermethrin | multiple interactions | EXP | | 6480464 | [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of BRCA1 protein | CTD | PMID:34896426 |
Brca1 | Rat | daidzein | increases expression | ISO | BRCA1 (Homo sapiens) | 6480464 | daidzein results in increased expression of BRCA1 mRNA | CTD | PMID:17266178 |
Brca1 | Rat | DDE | increases expression | ISO | BRCA1 (Homo sapiens) | 6480464 | Dichlorodiphenyl Dichloroethylene results in increased expression of BRCA1 mRNA | CTD | PMID:20206645 and PMID:38568856 |
Brca1 | Rat | DDE | multiple interactions | ISO | BRCA1 (Homo sapiens) | 6480464 | fulvestrant inhibits the reaction [Dichlorodiphenyl Dichloroethylene results in increased expression of BRCA1 mRNA] | CTD | PMID:20206645 |
Brca1 | Rat | Decamethylcyclopentasiloxane | decreases expression | ISO | BRCA1 (Homo sapiens) | 6480464 | decamethylcyclopentasiloxane results in decreased expression of BRCA1 protein | CTD | PMID:27601420 |
Brca1 | Rat | Decamethylcyclopentasiloxane | affects expression | ISO | BRCA1 (Homo sapiens) | 6480464 | decamethylcyclopentasiloxane affects the expression of BRCA1 mRNA | CTD | PMID:27601420 |
Brca1 | Rat | deguelin | decreases expression | ISO | BRCA1 (Homo sapiens) | 6480464 | deguelin results in decreased expression of BRCA1 mRNA | CTD | PMID:22227970 |
Brca1 | Rat | diamminedichloroplatinum | decreases activity | ISO | BRCA1 (Homo sapiens) | 6480464 | transplatin results in decreased activity of BRCA1 protein | CTD | PMID:20878461 |
Brca1 | Rat | diarsenic trioxide | increases expression | ISO | BRCA1 (Homo sapiens) | 6480464 | Arsenic Trioxide results in increased expression of BRCA1 mRNA | CTD | PMID:20458559 |
Brca1 | Rat | dibenzofuran | decreases expression | EXP | | 6480464 | dibenzofuran analog results in decreased expression of BRCA1 mRNA | CTD | PMID:20566336 |
Brca1 | Rat | dibutyl phthalate | decreases expression | ISO | Brca1 (Mus musculus) | 6480464 | Dibutyl Phthalate results in decreased expression of BRCA1 mRNA and Dibutyl Phthalate results in decreased expression of BRCA1 protein | CTD | PMID:21266533 and PMID:31318015 |
Brca1 | Rat | diclofenac | increases expression | ISO | Brca1 (Mus musculus) | 6480464 | Diclofenac results in increased expression of BRCA1 mRNA | CTD | PMID:26934552 |
Brca1 | Rat | dieldrin | affects expression | EXP | | 6480464 | Dieldrin affects the expression of BRCA1 mRNA | CTD | PMID:22546817 |
Brca1 | Rat | dinaciclib | decreases expression | ISO | BRCA1 (Homo sapiens) | 6480464 | dinaciclib results in decreased expression of BRCA1 mRNA and dinaciclib results in decreased expression of BRCA1 protein | CTD | PMID:27880910 |
Brca1 | Rat | dioxygen | decreases expression | ISO | BRCA1 (Homo sapiens) | 6480464 | Oxygen deficiency results in decreased expression of BRCA1 mRNA and Oxygen deficiency results in decreased expression of BRCA1 protein | CTD | PMID:17599377 more ... |
Brca1 | Rat | disodium selenite | decreases expression | ISO | BRCA1 (Homo sapiens) | 6480464 | Sodium Selenite results in decreased expression of BRCA1 mRNA | CTD | PMID:10344722 |
Brca1 | Rat | doxorubicin | decreases expression | ISO | BRCA1 (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of BRCA1 mRNA | CTD | PMID:10344722 more ... |
Brca1 | Rat | doxorubicin | multiple interactions | ISO | BRCA1 (Homo sapiens) | 6480464 | Doxorubicin inhibits the reaction [[RBBP8 protein binds to BRCA1 protein binds to E2F1 protein] which results in increased expression of ATM mRNA] and Doxorubicin inhibits the reaction [BRCA1 protein binds to ATM promoter] | CTD | PMID:22832221 |
Brca1 | Rat | emetine | multiple interactions | ISO | Brca1 (Mus musculus) | 6480464 | Emetine inhibits the reaction [Thapsigargin affects the localization of BRCA1 mRNA] | CTD | PMID:29576526 |
Brca1 | Rat | endosulfan | affects expression | ISO | BRCA1 (Homo sapiens) | 6480464 | Endosulfan affects the expression of BRCA1 mRNA | CTD | PMID:29705383 |
Brca1 | Rat | endosulfan | multiple interactions | ISO | BRCA1 (Homo sapiens) | 6480464 | 2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one inhibits the reaction [Endosulfan affects the expression of BRCA1 mRNA] | CTD | PMID:29705383 |
Brca1 | Rat | Enterolactone | multiple interactions | ISO | BRCA1 (Homo sapiens) | 6480464 | [Coumestrol co-treated with 2 and 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of BRCA1 mRNA | CTD | PMID:19167446 |
Brca1 | Rat | erlotinib hydrochloride | multiple interactions | ISO | BRCA1 (Homo sapiens) | 6480464 | [Erlotinib Hydrochloride results in decreased activity of EGFR protein] which results in decreased phosphorylation of BRCA1 protein | CTD | PMID:23548265 |
Brca1 | Rat | ethanol | multiple interactions | ISO | Brca1 (Mus musculus) | 6480464 | [BRCA1 gene mutant form results in increased susceptibility to Ethanol] which results in increased abundance of 8-Hydroxy-2'-Deoxyguanosine more ... | CTD | PMID:26629949 |
Brca1 | Rat | ethanol | increases response to substance | ISO | Brca1 (Mus musculus) | 6480464 | BRCA1 gene mutant form results in increased susceptibility to Ethanol | CTD | PMID:26629949 |
Brca1 | Rat | etoposide | multiple interactions | ISO | BRCA1 (Homo sapiens) | 6480464 | BRCA1 protein mutant form inhibits the reaction [Etoposide results in increased expression of CDK2 protein] more ... | CTD | PMID:16417649 and PMID:26259609 |
Brca1 | Rat | etoposide | increases expression | ISO | BRCA1 (Homo sapiens) | 6480464 | Etoposide results in increased expression of BRCA1 protein | CTD | PMID:26259609 |
Brca1 | Rat | etoposide | decreases expression | ISO | BRCA1 (Homo sapiens) | 6480464 | Etoposide results in decreased expression of BRCA1 mRNA | CTD | PMID:15607317 |
Brca1 | Rat | fenthion | decreases expression | ISO | BRCA1 (Homo sapiens) | 6480464 | Fenthion results in decreased expression of BRCA1 mRNA | CTD | PMID:33221015 |
Brca1 | Rat | fenvalerate | affects binding | ISO | BRCA1 (Homo sapiens) | 6480464 | fenvalerate binds to BRCA1 protein | CTD | PMID:32278787 |
Brca1 | Rat | fenvalerate | multiple interactions | EXP | | 6480464 | [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of BRCA1 protein | CTD | PMID:34896426 |
Brca1 | Rat | fenvalerate | increases expression | EXP | | 6480464 | fenvalerate results in increased expression of BRCA1 mRNA | CTD | PMID:30307764 |
Brca1 | Rat | flavonoids | increases expression | EXP | | 6480464 | Flavonoids results in increased expression of BRCA1 mRNA | CTD | PMID:18035473 |
Brca1 | Rat | folic acid | multiple interactions | ISO | Brca1 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of BRCA1 mRNA | CTD | PMID:20938992 |
Brca1 | Rat | folic acid | multiple interactions | ISO | BRCA1 (Homo sapiens) | 6480464 | [Folic Acid deficiency co-treated with Methotrexate] results in decreased expression of BRCA1 mRNA | CTD | PMID:24657277 |
Brca1 | Rat | FR900359 | affects phosphorylation | ISO | BRCA1 (Homo sapiens) | 6480464 | FR900359 affects the phosphorylation of BRCA1 protein | CTD | PMID:37730182 |
Brca1 | Rat | fulvestrant | decreases expression | ISO | BRCA1 (Homo sapiens) | 6480464 | Fulvestrant results in decreased expression of BRCA1 mRNA | CTD | PMID:20206645 and PMID:31646340 |
Brca1 | Rat | fulvestrant | multiple interactions | ISO | BRCA1 (Homo sapiens) | 6480464 | [bisphenol A co-treated with Fulvestrant] results in increased methylation of BRCA1 gene more ... | CTD | PMID:12473173 more ... |
Brca1 | Rat | furan | increases expression | EXP | | 6480464 | furan results in increased expression of BRCA1 mRNA | CTD | PMID:22079235 |
Brca1 | Rat | furan | decreases expression | EXP | | 6480464 | furan results in decreased expression of BRCA1 mRNA | CTD | PMID:25539665 |
Brca1 | Rat | furazolidone | increases expression | ISO | BRCA1 (Homo sapiens) | 6480464 | Furazolidone results in increased expression of BRCA1 protein | CTD | PMID:27996348 |
Brca1 | Rat | furazolidone | multiple interactions | ISO | BRCA1 (Homo sapiens) | 6480464 | Curcumin inhibits the reaction [Furazolidone results in increased expression of BRCA1 protein] | CTD | PMID:27996348 |
Brca1 | Rat | gemcitabine | decreases response to substance | ISO | Brca1 (Mus musculus) | 6480464 | BRCA1 results in decreased susceptibility to Gemcitabine | CTD | PMID:21771338 |
Brca1 | Rat | gemcitabine | increases expression | ISO | BRCA1 (Homo sapiens) | 6480464 | Gemcitabine results in increased expression of BRCA1 mRNA | CTD | PMID:20103597 |
Brca1 | Rat | genistein | multiple interactions | ISO | BRCA1 (Homo sapiens) | 6480464 | [indole-3-carbinol co-treated with Genistein] results in increased expression of BRCA1 protein and Genistein inhibits the reaction [sodium arsenite inhibits the reaction [Estradiol results in increased expression of BRCA1 protein]] | CTD | PMID:16434996 and PMID:30664189 |
Brca1 | Rat | genistein | increases expression | ISO | BRCA1 (Homo sapiens) | 6480464 | Genistein results in increased expression of BRCA1 mRNA and Genistein results in increased expression of BRCA1 protein | CTD | PMID:16434996 and PMID:17266178 |
Brca1 | Rat | gentamycin | decreases expression | EXP | | 6480464 | Gentamicins results in decreased expression of BRCA1 mRNA | CTD | PMID:33387578 |
Brca1 | Rat | geraniol | decreases expression | ISO | BRCA1 (Homo sapiens) | 6480464 | geraniol results in decreased expression of BRCA1 mRNA | CTD | PMID:27683099 |
Brca1 | Rat | glyphosate | decreases expression | ISO | BRCA1 (Homo sapiens) | 6480464 | Glyphosate results in decreased expression of BRCA1 mRNA | CTD | PMID:31295307 |
Brca1 | Rat | gold atom | multiple interactions | ISO | BRCA1 (Homo sapiens) | 6480464 | [Polyethyleneimine binds to Gold] which results in decreased expression of BRCA1 mRNA | CTD | PMID:28433809 |
Brca1 | Rat | gold atom | decreases expression | ISO | BRCA1 (Homo sapiens) | 6480464 | Gold analog results in decreased expression of BRCA1 mRNA | CTD | PMID:36057382 |
Brca1 | Rat | gold(0) | multiple interactions | ISO | BRCA1 (Homo sapiens) | 6480464 | [Polyethyleneimine binds to Gold] which results in decreased expression of BRCA1 mRNA | CTD | PMID:28433809 |
Brca1 | Rat | gold(0) | decreases expression | ISO | BRCA1 (Homo sapiens) | 6480464 | Gold analog results in decreased expression of BRCA1 mRNA | CTD | PMID:36057382 |
Brca1 | Rat | hexamethylcyclotrisiloxane | affects expression | ISO | BRCA1 (Homo sapiens) | 6480464 | hexamethylcyclotrisiloxane affects the expression of BRCA1 mRNA | CTD | PMID:27601420 |
Brca1 | Rat | hexamethylcyclotrisiloxane | decreases expression | ISO | BRCA1 (Homo sapiens) | 6480464 | hexamethylcyclotrisiloxane results in decreased expression of BRCA1 protein | CTD | PMID:27601420 |
Brca1 | Rat | hydrogen peroxide | decreases response to substance | ISO | BRCA1 (Homo sapiens) | 6480464 | BRCA1 protein results in decreased susceptibility to Hydrogen Peroxide | CTD | PMID:15520196 |
Brca1 | Rat | hydrogen peroxide | multiple interactions | ISO | Brca1 (Mus musculus) | 6480464 | N-(oxo-5 more ... | CTD | PMID:31494107 |
Brca1 | Rat | hydrogen peroxide | increases expression | ISO | BRCA1 (Homo sapiens) | 6480464 | Hydrogen Peroxide results in increased expression of BRCA1 mRNA | CTD | PMID:22539617 |
Brca1 | Rat | hydroquinone | increases expression | ISO | BRCA1 (Homo sapiens) | 6480464 | hydroquinone results in increased expression of BRCA1 protein | CTD | PMID:29421518 |
Brca1 | Rat | indole-3-methanol | multiple interactions | ISO | BRCA1 (Homo sapiens) | 6480464 | [indole-3-carbinol co-treated with Genistein] results in increased expression of BRCA1 protein more ... | CTD | PMID:11110848 more ... |
Brca1 | Rat | indole-3-methanol | increases expression | ISO | BRCA1 (Homo sapiens) | 6480464 | indole-3-carbinol results in increased expression of BRCA1 mRNA and indole-3-carbinol results in increased expression of BRCA1 protein | CTD | PMID:11110848 and PMID:16434996 |
Brca1 | Rat | L-methionine | multiple interactions | ISO | Brca1 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of BRCA1 mRNA | CTD | PMID:20938992 |
Brca1 | Rat | Lasiocarpine | multiple interactions | ISO | BRCA1 (Homo sapiens) | 6480464 | [CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of BRCA1 mRNA | CTD | PMID:33884520 |
Brca1 | Rat | Lasiocarpine | increases expression | ISO | BRCA1 (Homo sapiens) | 6480464 | lasiocarpine results in increased expression of BRCA1 mRNA | CTD | PMID:32234424 |
Brca1 | Rat | lead diacetate | decreases expression | ISO | Brca1 (Mus musculus) | 6480464 | lead acetate results in decreased expression of BRCA1 mRNA | CTD | PMID:22613225 |
Brca1 | Rat | leptomycin B | decreases expression | ISO | BRCA1 (Homo sapiens) | 6480464 | leptomycin B results in decreased expression of BRCA1 mRNA | CTD | PMID:20803015 |
Brca1 | Rat | leptomycin B | multiple interactions | ISO | BRCA1 (Homo sapiens) | 6480464 | [leptomycin B co-treated with TP53 gene mutant form] results in decreased expression of BRCA1 mRNA | CTD | PMID:20803015 |
Brca1 | Rat | lipopolysaccharide | multiple interactions | ISO | Brca1 (Mus musculus) | 6480464 | BAP1 inhibits the reaction [Lipopolysaccharides results in decreased expression of BRCA1 protein] and BAP1 protein inhibits the reaction [[Lipopolysaccharides results in decreased expression of BRCA1 protein] which results in increased phosphorylation of RELA protein] | CTD | PMID:37414201 |
Brca1 | Rat | lipopolysaccharide | decreases expression | ISO | Brca1 (Mus musculus) | 6480464 | Lipopolysaccharides results in decreased expression of BRCA1 protein | CTD | PMID:37414201 |
Brca1 | Rat | lucanthone | decreases expression | ISO | BRCA1 (Homo sapiens) | 6480464 | Lucanthone results in decreased expression of BRCA1 mRNA | CTD | PMID:21148553 |
Brca1 | Rat | manganese atom | multiple interactions | ISO | BRCA1 (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of BRCA1 mRNA | CTD | PMID:39836092 |
Brca1 | Rat | manganese(0) | multiple interactions | ISO | BRCA1 (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of BRCA1 mRNA | CTD | PMID:39836092 |
Brca1 | Rat | manganese(II) chloride | multiple interactions | ISO | BRCA1 (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of BRCA1 mRNA | CTD | PMID:39836092 |
Brca1 | Rat | methotrexate | multiple interactions | ISO | BRCA1 (Homo sapiens) | 6480464 | [Folic Acid deficiency co-treated with Methotrexate] results in decreased expression of BRCA1 mRNA and BRCA1 mutant form promotes the reaction [TP53 mutant form results in increased susceptibility to Methotrexate] | CTD | PMID:21875941 and PMID:24657277 |
Brca1 | Rat | methotrexate | increases expression | ISO | BRCA1 (Homo sapiens) | 6480464 | Methotrexate results in increased expression of BRCA1 mRNA | CTD | PMID:21678067 |
Brca1 | Rat | methoxsalen | multiple interactions | ISO | BRCA1 (Homo sapiens) | 6480464 | Methoxsalen inhibits the reaction [aflatoxin G1 results in increased expression of BRCA1 protein modified form] | CTD | PMID:23907605 |
Brca1 | Rat | methyl methanesulfonate | increases expression | ISO | BRCA1 (Homo sapiens) | 6480464 | Methyl Methanesulfonate results in increased expression of BRCA1 mRNA | CTD | PMID:23649840 |
Brca1 | Rat | mitomycin C | increases response to substance | ISO | BRCA1 (Homo sapiens) | 6480464 | BRCA1 protein mutant form results in increased susceptibility to Mitomycin | CTD | PMID:26320175 |
Brca1 | Rat | Monobutylphthalate | affects expression | EXP | | 6480464 | monobutyl phthalate affects the expression of BRCA1 mRNA | CTD | PMID:20864626 |
Brca1 | Rat | myristicin | decreases expression | ISO | BRCA1 (Homo sapiens) | 6480464 | myristicin results in decreased expression of BRCA1 mRNA | CTD | PMID:24792648 |
Brca1 | Rat | N-methyl-N'-nitro-N-nitrosoguanidine | increases expression | ISO | BRCA1 (Homo sapiens) | 6480464 | Methylnitronitrosoguanidine results in increased expression of BRCA1 mRNA | CTD | PMID:12634122 |
Brca1 | Rat | N-nitrosodiethylamine | increases expression | ISO | Brca1 (Mus musculus) | 6480464 | Diethylnitrosamine results in increased expression of BRCA1 mRNA | CTD | PMID:17854601 |
Brca1 | Rat | N-nitrosodiethylamine | multiple interactions | ISO | Brca1 (Mus musculus) | 6480464 | RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of BRCA1 mRNA] | CTD | PMID:17854601 |
Brca1 | Rat | nickel dichloride | decreases expression | ISO | BRCA1 (Homo sapiens) | 6480464 | nickel chloride results in decreased expression of BRCA1 mRNA and nickel chloride results in decreased expression of BRCA1 protein | CTD | PMID:28472268 |
Brca1 | Rat | nicotine | decreases expression | ISO | BRCA1 (Homo sapiens) | 6480464 | Nicotine results in decreased expression of BRCA1 mRNA | CTD | PMID:18247414 |
Brca1 | Rat | nicotine | multiple interactions | ISO | BRCA1 (Homo sapiens) | 6480464 | Nicotine inhibits the reaction [aflatoxin G1 results in increased expression of BRCA1 protein modified form] | CTD | PMID:23907605 |
Brca1 | Rat | nitrogen mustard | decreases expression | ISO | BRCA1 (Homo sapiens) | 6480464 | Nitrogen Mustard Compounds results in decreased expression of BRCA1 mRNA | CTD | PMID:10344722 |
Brca1 | Rat | nitrogen mustard | multiple interactions | ISO | BRCA1 (Homo sapiens) | 6480464 | Cycloheximide inhibits the reaction [Nitrogen Mustard Compounds results in decreased expression of BRCA1 mRNA] | CTD | PMID:10344722 |
Brca1 | Rat | O-methyleugenol | decreases expression | EXP | | 6480464 | methyleugenol results in decreased expression of BRCA1 mRNA | CTD | PMID:21659616 and PMID:26011634 |
Brca1 | Rat | ochratoxin A | increases expression | EXP | | 6480464 | ochratoxin A results in increased expression of BRCA1 mRNA | CTD | PMID:37162024 |
Brca1 | Rat | octamethylcyclotetrasiloxane | decreases expression | ISO | BRCA1 (Homo sapiens) | 6480464 | octamethylcyclotetrasiloxane results in decreased expression of BRCA1 protein | CTD | PMID:27601420 |
Brca1 | Rat | octamethylcyclotetrasiloxane | affects expression | ISO | BRCA1 (Homo sapiens) | 6480464 | octamethylcyclotetrasiloxane affects the expression of BRCA1 mRNA | CTD | PMID:27601420 |
Brca1 | Rat | olaparib | affects response to substance | ISO | BRCA1 (Homo sapiens) | 6480464 | BRCA1 affects the susceptibility to olaparib | CTD | PMID:21633166 |
Brca1 | Rat | olaparib | multiple interactions | ISO | BRCA1 (Homo sapiens) | 6480464 | [BRD4 protein affects the susceptibility to olaparib] which affects the expression of BRCA1 protein more ... | CTD | PMID:29567272 |
Brca1 | Rat | ouabain | decreases expression | ISO | BRCA1 (Homo sapiens) | 6480464 | Ouabain results in decreased expression of BRCA1 protein | CTD | PMID:31436044 |
Brca1 | Rat | oxaliplatin | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of BRCA1 mRNA | CTD | PMID:25729387 |
Brca1 | Rat | oxaliplatin | decreases activity | ISO | BRCA1 (Homo sapiens) | 6480464 | oxaliplatin results in decreased activity of BRCA1 protein | CTD | PMID:20878461 |
Brca1 | Rat | oxybenzone | increases expression | ISO | BRCA1 (Homo sapiens) | 6480464 | oxybenzone results in increased expression of BRCA1 mRNA | CTD | PMID:36581016 |
Brca1 | Rat | ozone | decreases expression | ISO | Brca1 (Mus musculus) | 6480464 | Ozone results in decreased expression of BRCA1 mRNA | CTD | PMID:24336422 |
Brca1 | Rat | ozone | increases expression | ISO | BRCA1 (Homo sapiens) | 6480464 | Ozone results in increased expression of BRCA1 mRNA | CTD | PMID:23033980 |
Brca1 | Rat | ozone | multiple interactions | ISO | BRCA1 (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of BRCA1 mRNA more ... | CTD | PMID:32699268 |
Brca1 | Rat | ozone | multiple interactions | ISO | Brca1 (Mus musculus) | 6480464 | [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of BRCA1 mRNA more ... | CTD | PMID:25658374 more ... |
Brca1 | Rat | paclitaxel | decreases expression | ISO | BRCA1 (Homo sapiens) | 6480464 | Paclitaxel results in decreased expression of BRCA1 mRNA | CTD | PMID:15607317 |
Brca1 | Rat | paracetamol | affects expression | ISO | Brca1 (Mus musculus) | 6480464 | Acetaminophen affects the expression of BRCA1 mRNA | CTD | PMID:17562736 |
Brca1 | Rat | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of BRCA1 mRNA | CTD | PMID:33387578 |
Brca1 | Rat | paracetamol | increases expression | ISO | Brca1 (Mus musculus) | 6480464 | Acetaminophen results in increased expression of BRCA1 protein | CTD | PMID:29540258 |
Brca1 | Rat | paracetamol | increases activity | EXP | | 6480464 | Acetaminophen results in increased activity of BRCA1 protein | CTD | PMID:25858767 |
Brca1 | Rat | paracetamol | increases expression | ISO | BRCA1 (Homo sapiens) | 6480464 | Acetaminophen results in increased expression of BRCA1 mRNA | CTD | PMID:22230336 |
Brca1 | Rat | paracetamol | decreases expression | ISO | Brca1 (Mus musculus) | 6480464 | Acetaminophen results in decreased expression of BRCA1 mRNA | CTD | PMID:17942131 |
Brca1 | Rat | paraquat | decreases response to substance | ISO | BRCA1 (Homo sapiens) | 6480464 | BRCA1 protein results in decreased susceptibility to Paraquat | CTD | PMID:15520196 |
Brca1 | Rat | paraquat | multiple interactions | ISO | Brca1 (Mus musculus) | 6480464 | [ATG7 protein affects the susceptibility to Paraquat] which affects the expression of BRCA1 mRNA | CTD | PMID:28012437 |
Brca1 | Rat | PCB138 | multiple interactions | ISO | BRCA1 (Homo sapiens) | 6480464 | 2 more ... | CTD | PMID:12473173 |
Brca1 | Rat | phenobarbital | affects expression | ISO | BRCA1 (Homo sapiens) | 6480464 | Phenobarbital affects the expression of BRCA1 mRNA | CTD | PMID:19159669 |
Brca1 | Rat | phenobarbital | affects expression | ISO | Brca1 (Mus musculus) | 6480464 | Phenobarbital affects the expression of BRCA1 mRNA | CTD | PMID:23091169 |
Brca1 | Rat | PhIP | decreases expression | EXP | | 6480464 | 2-amino-1-methyl-6-phenylimidazo(4 and 5-b)pyridine results in decreased expression of BRCA1 protein | CTD | PMID:12203372 |
Brca1 | Rat | phorbol 13-acetate 12-myristate | multiple interactions | ISO | Brca1 (Mus musculus) | 6480464 | [sodium arsenite co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of BRCA1 mRNA | CTD | PMID:16368122 |
Brca1 | Rat | phosphoramide mustard | affects expression | EXP | | 6480464 | phosphoramide mustard affects the expression of BRCA1 mRNA | CTD | PMID:25497287 |
Brca1 | Rat | phosphoramide mustard | increases expression | EXP | | 6480464 | phosphoramide mustard results in increased expression of BRCA1 mRNA and phosphoramide mustard results in increased expression of BRCA1 protein | CTD | PMID:25497287 and PMID:26708502 |
Brca1 | Rat | pifithrin-alpha hydrobromide | multiple interactions | ISO | BRCA1 (Homo sapiens) | 6480464 | pifithrin inhibits the reaction [Etoposide results in increased expression of and affects the localization of BRCA1 protein] | CTD | PMID:26259609 |
Brca1 | Rat | pirinixic acid | multiple interactions | ISO | Brca1 (Mus musculus) | 6480464 | PPARA protein promotes the reaction [pirinixic acid results in increased expression of BRCA1 mRNA] | CTD | PMID:17950772 |
Brca1 | Rat | pirinixic acid | decreases expression | ISO | Brca1 (Mus musculus) | 6480464 | pirinixic acid results in decreased expression of BRCA1 mRNA | CTD | PMID:23811191 |
Brca1 | Rat | pirinixic acid | increases expression | ISO | Brca1 (Mus musculus) | 6480464 | pirinixic acid results in increased expression of BRCA1 mRNA | CTD | PMID:17950772 |
Brca1 | Rat | potassium bromate | increases expression | ISO | BRCA1 (Homo sapiens) | 6480464 | potassium bromate results in increased expression of BRCA1 mRNA | CTD | PMID:22539617 |
Brca1 | Rat | potassium chromate | decreases expression | ISO | BRCA1 (Homo sapiens) | 6480464 | potassium chromate(VI) results in decreased expression of BRCA1 mRNA | CTD | PMID:22079256 |
Brca1 | Rat | potassium chromate | multiple interactions | ISO | BRCA1 (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of BRCA1 mRNA | CTD | PMID:22079256 |
Brca1 | Rat | pregnenolone 16alpha-carbonitrile | multiple interactions | ISO | Brca1 (Mus musculus) | 6480464 | [1 more ... | CTD | PMID:23626729 |
Brca1 | Rat | procyanidin B2 | increases expression | ISO | BRCA1 (Homo sapiens) | 6480464 | procyanidin B2 results in increased expression of BRCA1 mRNA | CTD | PMID:25839702 |
Brca1 | Rat | promethazine | decreases expression | EXP | | 6480464 | Promethazine results in decreased expression of BRCA1 mRNA | CTD | PMID:26011634 |
Brca1 | Rat | propanal | decreases expression | ISO | BRCA1 (Homo sapiens) | 6480464 | propionaldehyde results in decreased expression of BRCA1 mRNA | CTD | PMID:26079696 |
Brca1 | Rat | pyrethrins | decreases expression | EXP | | 6480464 | Pyrethrins results in decreased expression of BRCA1 protein | CTD | PMID:34896426 |
Brca1 | Rat | quercetin | increases expression | ISO | BRCA1 (Homo sapiens) | 6480464 | Quercetin results in increased expression of BRCA1 mRNA | CTD | PMID:14715546 and PMID:21632981 |
Brca1 | Rat | quercetin | decreases expression | ISO | BRCA1 (Homo sapiens) | 6480464 | Quercetin results in decreased expression of BRCA1 mRNA | CTD | PMID:36982678 |
Brca1 | Rat | reactive oxygen species | multiple interactions | ISO | BRCA1 (Homo sapiens) | 6480464 | BRCA1 inhibits the reaction [Benzo(a)pyrene results in increased abundance of Reactive Oxygen Species] and NFE2L2 protein inhibits the reaction [BRCA1 inhibits the reaction [Benzo(a)pyrene results in increased abundance of Reactive Oxygen Species]] | CTD | PMID:22192953 |
Brca1 | Rat | resveratrol | increases expression | ISO | BRCA1 (Homo sapiens) | 6480464 | resveratrol results in increased expression of BRCA1 mRNA and resveratrol results in increased expression of BRCA1 protein | CTD | PMID:15149879 and PMID:25533949 |
Brca1 | Rat | resveratrol | decreases expression | EXP | | 6480464 | Resveratrol results in decreased expression of BRCA1 mRNA | CTD | PMID:33775663 |
Brca1 | Rat | resveratrol | affects localization | ISO | BRCA1 (Homo sapiens) | 6480464 | resveratrol affects the localization of BRCA1 protein | CTD | PMID:19559722 |
Brca1 | Rat | resveratrol | multiple interactions | ISO | BRCA1 (Homo sapiens) | 6480464 | [Coumestrol co-treated with Resveratrol] results in increased expression of BRCA1 mRNA more ... | CTD | PMID:19167446 more ... |
Brca1 | Rat | resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of BRCA1 mRNA and resveratrol results in increased expression of BRCA1 protein | CTD | PMID:24136580 |
Brca1 | Rat | resveratrol | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [DNMT1 protein binds to BRCA1 promoter]] more ... | CTD | PMID:24136580 |
Brca1 | Rat | riddelliine | multiple interactions | ISO | BRCA1 (Homo sapiens) | 6480464 | [CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of BRCA1 mRNA | CTD | PMID:33884520 |
Brca1 | Rat | rotenone | increases expression | ISO | BRCA1 (Homo sapiens) | 6480464 | Rotenone results in increased expression of BRCA1 mRNA | CTD | PMID:18191903 |
Brca1 | Rat | rucaparib | affects response to substance | ISO | BRCA1 (Homo sapiens) | 6480464 | BRCA1 protein affects the susceptibility to rucaparib | CTD | PMID:32927276 |
Brca1 | Rat | silicon dioxide | increases expression | ISO | Brca1 (Mus musculus) | 6480464 | Silicon Dioxide results in increased expression of BRCA1 mRNA | CTD | PMID:29341224 |
Brca1 | Rat | sodium arsenite | affects expression | ISO | Brca1 (Mus musculus) | 6480464 | sodium arsenite affects the expression of BRCA1 mRNA | CTD | PMID:16507464 |
Brca1 | Rat | sodium arsenite | increases methylation | ISO | BRCA1 (Homo sapiens) | 6480464 | sodium arsenite results in increased methylation of BRCA1 gene | CTD | PMID:30664189 |
Brca1 | Rat | sodium arsenite | decreases expression | ISO | BRCA1 (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of BRCA1 mRNA and sodium arsenite results in decreased expression of BRCA1 protein | CTD | PMID:30664189 and PMID:38568856 |
Brca1 | Rat | sodium arsenite | multiple interactions | ISO | BRCA1 (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of BRCA1 mRNA more ... | CTD | PMID:30664189 more ... |
Brca1 | Rat | sodium arsenite | multiple interactions | ISO | Brca1 (Mus musculus) | 6480464 | [sodium arsenite co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of BRCA1 mRNA | CTD | PMID:16368122 |
Brca1 | Rat | sodium arsenite | increases expression | ISO | BRCA1 (Homo sapiens) | 6480464 | sodium arsenite results in increased expression of BRCA1 mRNA | CTD | PMID:12760830 and PMID:29301061 |
Brca1 | Rat | sodium dichromate | increases expression | ISO | Brca1 (Mus musculus) | 6480464 | sodium bichromate results in increased expression of BRCA1 mRNA | CTD | PMID:22155349 |
Brca1 | Rat | succimer | multiple interactions | ISO | Brca1 (Mus musculus) | 6480464 | [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of BRCA1 mRNA and [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of BRCA1 mRNA | CTD | PMID:21641980 and PMID:26378955 |
Brca1 | Rat | sulindac | decreases expression | ISO | BRCA1 (Homo sapiens) | 6480464 | Sulindac results in decreased expression of BRCA1 mRNA | CTD | PMID:16273229 |
Brca1 | Rat | talazoparib | increases response to substance | ISO | BRCA1 (Homo sapiens) | 6480464 | BRCA1 gene mutant form results in increased susceptibility to talazoparib | CTD | PMID:30672063 |
Brca1 | Rat | tamibarotene | decreases expression | ISO | BRCA1 (Homo sapiens) | 6480464 | tamibarotene results in decreased expression of BRCA1 mRNA | CTD | PMID:15498508 |
Brca1 | Rat | tamoxifen | affects activity | ISO | BRCA1 (Homo sapiens) | 6480464 | BRCA1 affects the activity of Tamoxifen | CTD | PMID:15750629 |
Brca1 | Rat | tamoxifen | multiple interactions | ISO | Brca1 (Mus musculus) | 6480464 | [Tamoxifen co-treated with BRCA1 protein mutant form] results in decreased expression of ESR1 protein | CTD | PMID:15750629 |
Brca1 | Rat | tamoxifen | increases response to substance | ISO | BRCA1 (Homo sapiens) | 6480464 | BRCA1 protein results in increased susceptibility to Tamoxifen | CTD | PMID:18997820 |
Brca1 | Rat | tamoxifen | multiple interactions | ISO | BRCA1 (Homo sapiens) | 6480464 | [Tamoxifen co-treated with Estradiol] results in increased expression of BRCA1 protein more ... | CTD | PMID:18997820 and PMID:30664189 |
Brca1 | Rat | terbufos | decreases expression | ISO | BRCA1 (Homo sapiens) | 6480464 | terbufos results in decreased expression of BRCA1 mRNA | CTD | PMID:33221015 |
Brca1 | Rat | testosterone | multiple interactions | ISO | BRCA1 (Homo sapiens) | 6480464 | [Testosterone co-treated with Calcitriol] results in decreased expression of BRCA1 mRNA more ... | CTD | PMID:21592394 |
Brca1 | Rat | testosterone | decreases expression | ISO | BRCA1 (Homo sapiens) | 6480464 | Testosterone results in decreased expression of BRCA1 mRNA | CTD | PMID:21592394 |
Brca1 | Rat | tetrachloromethane | affects expression | EXP | | 6480464 | Carbon Tetrachloride affects the expression of BRCA1 mRNA | CTD | PMID:12734012 |
Brca1 | Rat | tetrachloromethane | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of BRCA1 mRNA] | CTD | PMID:31150632 |
Brca1 | Rat | tetrachloromethane | decreases expression | EXP | | 6480464 | Carbon Tetrachloride results in decreased expression of BRCA1 mRNA | CTD | PMID:31150632 |
Brca1 | Rat | tetrachloromethane | increases expression | ISO | Brca1 (Mus musculus) | 6480464 | Carbon Tetrachloride results in increased expression of BRCA1 mRNA | CTD | PMID:17484886 |
Brca1 | Rat | tetramethrin | affects binding | ISO | BRCA1 (Homo sapiens) | 6480464 | tetramethrin binds to BRCA1 protein | CTD | PMID:32278787 |
Brca1 | Rat | thapsigargin | increases expression | ISO | BRCA1 (Homo sapiens) | 6480464 | Thapsigargin results in increased expression of BRCA1 mRNA and Thapsigargin results in increased expression of BRCA1 protein | CTD | PMID:16434996 |
Brca1 | Rat | thapsigargin | affects localization | ISO | Brca1 (Mus musculus) | 6480464 | Thapsigargin affects the localization of BRCA1 mRNA | CTD | PMID:29576526 |
Brca1 | Rat | thapsigargin | multiple interactions | ISO | Brca1 (Mus musculus) | 6480464 | Cycloheximide inhibits the reaction [Thapsigargin affects the localization of BRCA1 mRNA] and Emetine inhibits the reaction [Thapsigargin affects the localization of BRCA1 mRNA] | CTD | PMID:29576526 |
Brca1 | Rat | thioacetamide | decreases expression | EXP | | 6480464 | Thioacetamide results in decreased expression of BRCA1 mRNA | CTD | PMID:26011634 |
Brca1 | Rat | topotecan | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of BRCA1 mRNA | CTD | PMID:25729387 |
Brca1 | Rat | topotecan | decreases expression | EXP | | 6480464 | Topotecan results in decreased expression of BRCA1 mRNA | CTD | PMID:25729387 |
Brca1 | Rat | toxaphene | increases expression | ISO | BRCA1 (Homo sapiens) | 6480464 | Toxaphene results in increased expression of BRCA1 mRNA | CTD | PMID:12473173 |
Brca1 | Rat | transplatin | decreases activity | ISO | BRCA1 (Homo sapiens) | 6480464 | transplatin results in decreased activity of BRCA1 protein | CTD | PMID:20878461 |
Brca1 | Rat | Tributyltin oxide | decreases expression | ISO | Brca1 (Mus musculus) | 6480464 | bis(tri-n-butyltin)oxide results in decreased expression of BRCA1 mRNA | CTD | PMID:17942131 |
Brca1 | Rat | trichostatin A | decreases expression | ISO | BRCA1 (Homo sapiens) | 6480464 | trichostatin A results in decreased expression of BRCA1 mRNA | CTD | PMID:23770000 |
Brca1 | Rat | triclosan | decreases expression | ISO | BRCA1 (Homo sapiens) | 6480464 | Triclosan results in decreased expression of BRCA1 mRNA | CTD | PMID:30510588 |
Brca1 | Rat | trimellitic anhydride | increases expression | ISO | Brca1 (Mus musculus) | 6480464 | trimellitic anhydride results in increased expression of BRCA1 mRNA | CTD | PMID:19042947 |
Brca1 | Rat | troglitazone | decreases expression | ISO | BRCA1 (Homo sapiens) | 6480464 | troglitazone results in decreased expression of BRCA1 mRNA | CTD | PMID:19140230 |
Brca1 | Rat | trovafloxacin | decreases expression | ISO | Brca1 (Mus musculus) | 6480464 | trovafloxacin results in decreased expression of BRCA1 mRNA | CTD | PMID:35537566 |
Brca1 | Rat | tungsten | decreases expression | ISO | Brca1 (Mus musculus) | 6480464 | Tungsten results in decreased expression of BRCA1 mRNA | CTD | PMID:30912803 |
Brca1 | Rat | tunicamycin | increases expression | ISO | BRCA1 (Homo sapiens) | 6480464 | Tunicamycin results in increased expression of BRCA1 protein | CTD | PMID:16434996 |
Brca1 | Rat | urethane | decreases expression | ISO | BRCA1 (Homo sapiens) | 6480464 | Urethane results in decreased expression of BRCA1 mRNA | CTD | PMID:28818685 |
Brca1 | Rat | valproic acid | decreases expression | ISO | BRCA1 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of BRCA1 mRNA | CTD | PMID:20585447 and PMID:28001369 |
Brca1 | Rat | valproic acid | decreases expression | ISO | Brca1 (Mus musculus) | 6480464 | Valproic Acid results in decreased expression of BRCA1 mRNA | CTD | PMID:24913804 |
Brca1 | Rat | valproic acid | increases expression | ISO | Brca1 (Mus musculus) | 6480464 | Valproic Acid results in increased expression of BRCA1 mRNA | CTD | PMID:24913804 |
Brca1 | Rat | valproic acid | increases methylation | ISO | BRCA1 (Homo sapiens) | 6480464 | Valproic Acid results in increased methylation of BRCA1 gene | CTD | PMID:29154799 |
Brca1 | Rat | veliparib | affects response to substance | ISO | BRCA1 (Homo sapiens) | 6480464 | BRCA1 affects the susceptibility to veliparib | CTD | PMID:21633166 |
Brca1 | Rat | veliparib | decreases response to substance | ISO | BRCA1 (Homo sapiens) | 6480464 | BRCA1 protein results in decreased susceptibility to veliparib | CTD | PMID:21707865 |
Brca1 | Rat | vorinostat | multiple interactions | ISO | BRCA1 (Homo sapiens) | 6480464 | vorinostat inhibits the reaction [BRCA1 results in decreased susceptibility to Cisplatin] | CTD | PMID:21854619 |
Brca1 | Rat | vorinostat | decreases expression | ISO | BRCA1 (Homo sapiens) | 6480464 | vorinostat results in decreased expression of BRCA1 protein | CTD | PMID:21854619 |
Brca1 | Rat | zearalenone | increases expression | ISO | Brca1 (Mus musculus) | 6480464 | Zearalenone results in increased expression of BRCA1 mRNA | CTD | PMID:28552778 |
Brca1 | Rat | zearalenone | increases expression | ISO | BRCA1 (Homo sapiens) | 6480464 | Zearalenone results in increased expression of BRCA1 mRNA | CTD | PMID:28965971 |
Brca1 | Rat | zinc atom | affects binding | ISO | BRCA1 (Homo sapiens) | 6480464 | Zinc binds to BRCA1 protein | CTD | PMID:36087615 |
Brca1 | Rat | zinc atom | multiple interactions | ISO | BRCA1 (Homo sapiens) | 6480464 | sodium arsenite inhibits the reaction [Zinc binds to BRCA1 protein] | CTD | PMID:36087615 |
Brca1 | Rat | zinc(0) | affects binding | ISO | BRCA1 (Homo sapiens) | 6480464 | Zinc binds to BRCA1 protein | CTD | PMID:36087615 |
Brca1 | Rat | zinc(0) | multiple interactions | ISO | BRCA1 (Homo sapiens) | 6480464 | sodium arsenite inhibits the reaction [Zinc binds to BRCA1 protein] | CTD | PMID:36087615 |